PRENATAL GENETIC SERVICES
Everything you need for Healthy Baby
Despite the continuous technological advances in modern medicine, it is our untimely reality that many preliminary mothers are still experiencing difficulties. In order to overcome the difficulties, medical treatment has been the main focus, but at the same time, a comprehensive diagnosis focusing on screening tests is needed to conceive a healthy baby. We provide state-of-the-art genetic diagnostic technology to test not only the fetus but also the health of women.
E-NIPT
(Expanded Non-Invasive Prenatal Test)
“Non-Invasive Prenatal Test (NIPT)" is the fetal genome screening of chromosomal abnormalities and fetal genome tests have been conducted for high-risk pregnant women.
Thanks to the newest NGS technologies, chromosomal abnormalities are non-invasively detectable with over 99% confident sensitivity and specificity level.
GENOMOMAI
PGT
(Preimplantation Genetic Test)
Preimplantation genetic test (PGT) for aneuploidy is a powerful genetic test that may be performed on embryos during IVF treatment to screen for numerical chromosomal abnormalities. PGT testing helps IVF physicians and patients decide which embryos to transfer.
Sate-of-art NGS based PGT accelerate to maximize the accuracy & efficacy of embryo selection by whole genome sequencing technology.
GENOBRO
a25fad
GENOBENET
Newborn Screening (NBS) is screening test for detecting certain specific chromosomal abnormalities of newborn baby using NGS (next-generation sequencing) and its applied analysis technology.
Most of inborn genetic malfunctioned conditions are treatable genetic disorders.Prompt identification, intervention and treatment for these conditions can prevent death or irreversible disability.
NBS by NGS
(NGS-based Newborn Screening)
E-NIPT
(Expanded Non-Invasive Prenatal Test)
“Non-Invasive Prenatal Test (NIPT)" is the fetal genome screening of chromosomal abnormalities and fetal genome tests have been conducted for high-risk pregnant women.
Thanks to the newest NGS technologies, chromosomal abnormalities are non-invasively detectable with over 99% confident sensitivity and specificity level.
GENOMOMAI
Preimplantation genetic test (PGT) for aneuploidy is a powerful genetic test that may be performed on embryos during IVF treatment to screen for numerical chromosomal abnormalities. PGT testing helps IVF physicians and patients decide which embryos to transfer.
Sate-of-art NGS based PGT accelerate to maximize the accuracy & efficacy of embryo selection by whole genome sequencing technology.
PGT
(Preimplantation Genetic Test)
GENOBRO
GENOBENET
Newborn Screening (NBS) is screening test for detecting certain specific chromosomal abnormalities of newborn baby using NGS (next-generation sequencing) and its applied analysis technology.
Most of inborn genetic malfunctioned conditions are treatable genetic disorders.Prompt identification, intervention and treatment for these conditions can prevent death or irreversible disability.
NBS by NGS
(NGS-based Newborn Screening)
GENOFIND
NGS
(Next-Generation Sequencing)
Chromosomal analysis of products of conception (POC) is performed by collecting a portion of the fetal tissue after miscarriage to identify numerical chromosomal abnormalities.
This test focuses on analyzing fetal genetic factors among the various causes of miscarriage and provides essential genetic counseling information to help plan future pregnancies.
ORA™
ORA
(Optimal Receptivity Analysis)
The Optimal Receptivity Analysis (ORA™) is a non-invasive test that analyzes a patient's blood sample using next-generation sequencing (NGS) technology to determine the optimal window of implantation (WOI) for patients who have experienced recurrent implantation failure (RIF).
The WOI refers to the most favorable period within a menstrual cycle for embryo implantation, and since the timing can vary from person to person, a personalized evaluation is essential.